Professor Carolyn Taylor
Carolyn Taylor
BM BCh (oxon) MA MRCP FRCR DPhil
Professor, Clinical Research Fellow and Honorary Consultant Oncologist
Carolyn Taylor is a consultant clinical oncologist and professor of oncology. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008.
She now provides clinical leadership in large international collaborations including oncologists, epidemiologists, statisticians and cancer registry staff.
She works in the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) on trials of surgery and radiotherapy.
She is Principal Investigator on a Cancer Research UK research program on the benefits and risks of cancer treatments. This programme combines information from high quality datasets to produce estimates of benefits and risks for use by oncologists in the clinic today.
Recent publications
-
TEMPORARY REMOVAL: Estimated doses to the heart, lungs and oesophagus and risks from typical UK radiotherapy for early breast cancer during 2015-2023
Journal article
Holt F. et al, (2024), Clinical Oncology
-
Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2023), Lancet, 402, 1991 - 2003
-
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
Journal article
Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882
-
Authors' reply to Oke and Welch.
Journal article
Darby SC. et al, (2023), BMJ, 382
-
Ki67 and breast cancer mortality in women with invasive breast cancer.
Journal article
Probert J. et al, (2023), JNCI Cancer Spectr, 7